✦ LIBER ✦

Predictive factors for anthracycline-based chemotherapy for human breast cancer

✍ Scribed by Yasuo Miyoshi; Masafumi Kurosumi; Junichi Kurebayashi; Nariaki Matsuura; Masato Takahashi; Eriko Tokunaga; Chiyomi Egawa; Norikazu Masuda; Seishi Kono; Koji Morimoto; Seung Jin Kim; Masatsugu Okishiro; Tetsu Yanagisawa; Satsuki Ueda; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi

Book ID: 107643774
Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 163 KB
Volume: 17
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-009-0152-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimum anthracycline-based chemotherapy

Optimum anthracycline-based chemotherapy for early breast cancer

✍ Julian W Adlard; David J Dodwell 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 312 KB

Predictors of inflammation in response t

Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer

✍ Paul J. Mills; Sonia Ancoli-Israel; Barbara Parker; Loki Natarajan; Suzi Hong; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

TOP2Aamplification in breast cancer is a

TOP2Aamplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

✍ Jiayu Wang, Binghe Xu, Peng Yuan, Pin Zhang, Qing Li, Fei Ma, Ying Fan 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 242 KB

Analysis of functional germline polymorp

Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer

✍ Szkandera, Joanna; Absenger, Gudrun; Dandachi, Nadia; Regitnig, Peter; Lax, Sigu 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 236 KB

Gene expression profile predicts outcome

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

✍ François Bertucci; Nathalie Borie; Henri Roche; Thomas Bachelot; Jean-Marc Le Do 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 786 KB

Breast-conserving surgery after neoadjuv

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

✍ Roman Rouzier; Marie-Christine Mathieu; Lucas Sideris; Esther Youmsi; Radhika Ra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Randomized trials comparing neoadjuvant versus adjuvant chemotherapy show that primary chemotherapy allows more frequent breast‐preserving surgery even though no survival advantage has been demonstrated. The aim of the current study was to determine the predicting factors